Y-27632 dihydrochloride, Rho kinase inhibitor
5
(2 Reviews)
|
(153 Publications)
Y-27632 dihydrochloride (ab120129) is a cell-permeable, selective Rho kinase (ROCK) inhibitor. Molecular weight (MW) 320.3, Purity >99%.
- Suitable for stem cell maintenance and differentiation assays
- Used as component in 3D growth matrix and brain organoid differentiation media
- Available in multiple sizes to fit your experimental needs
- Cited in over 125 publications
View Alternative Names
CP2D6_HUMAN, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, Cardiolipin activated protein kinase Pak2, Cholesterol 25-hydroxylase, Cytochrome P450 2D6, Cytochrome P450 family 2 subfamily D member 6, Cytochrome P450 family 2 subfamily D polypeptide 6, Cytochrome P450-DB1, Debrisoquine 4-hydroxylase, KIAA0619, KPCE_HUMAN, MGC125656, MGC125657, MGC131603, MGC150606, MGC43611, MGC71074, Microsomal monooxygenase, P450 DB1, P450C2D, PKCE, PKN gamma, PKN2_HUMAN, PRK2, PRKCE, PRKCL2, PRO0435, PRO2042, Pkcea, Protein kinase C epsilon, Protein kinase C epsilon type, Protein kinase C-like 2, Protein kinase N2, Protein-kinase C-related kinase 2, ROCK-I, ROCK1_HUMAN, ROCK2_HUMAN, ROK alpha, Renal carcinoma antigen NY-REN-35, Rho associated coiled coil containing protein kinase 1, Rho associated coiled coil containing protein kinase 2, Rho associated, coiled coil containing protein kinase II, Rho kinase, Rho kinase 2, Rho-alpha kinase, Rho-associated, Rho-associated protein kinase 1, Rho-associated protein kinase 2, Rock II, Rock2m, Rok, Serine/threonine-protein kinase N2, Xenobiotic monooxygenase, coiled-coil-containing protein kinase 1, coiled-coil-containing protein kinase 2, coiled-coil-containing protein kinase I, flavoprotein-linked monooxygenase, nPKC-epsilon, p160 ROCK, p160 ROCK-1, p160 Rhoassociated coiled coil-forming protein kinase, p164 ROCK-2, Y27632
- FuncS
Unknown
Functional Studies - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)
ab46154 staining VEGF in HeLa cells treated with Y-27632 dihydrochloride (ab120129), by ICC/IF. Decrease in VEGF expression correlates with increased concentration of Y-27632 dihydrochloride, as described in literature.
The cells were incubated at 37°C for 1h in media containing different concentrations of ab120129 (Y-27632 dihydrochloride) in DMSO, fixed with 100% methanol for 5 minutes at -20°C and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab46154 (5 μg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
- FuncS
PubMed
Functional Studies - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)
A : Serum-starved human TM cells were incubated on chamber glass slides coated with recombinant human Gal8 in the presence of the ROCK inhibitor ab120129, at different concentrations. After 2 hr, cells were stained with rhodamine-labeled phalloidin, and cells with robust stress fibers were enumerated. Data are expressed as mean±SEM.
B : Cells were treated with an 120129 (Y27632) at 20 μM, stained with rhodamine-labeled phalloidin, and random fields were photographed. Note that cells treated with ab120129 are not spread and exhibit dendrite-like structures.
Credit : Shiri D et al. PLoS One. 2012; 7(7) : e41958. doi : 10.1371/journal.pone.0044400
Shiri D et al. PLoS One. 2012; 7(7): e41958. doi: 10.1371/journal.pone.0044400 Reproduced under the Creative Commons license http://creativecommons.org/licenses/by/4.0/
- Chemical Structure
Lab
Chemical Structure - Y-27632 dihydrochloride, Rho kinase inhibitor (AB120129)
2D chemical structure image of ab120129, Y-27632 dihydrochloride, Rho kinase inhibitor
Product details
Y-27632 is a research tool with a wide variety of biological effects, mainly used in the field of stem cell research for maintenance and differentiation. Commonly used as 3D growth matrix component; also a component of brain organoid differentiation media.
How others have used Y-27632 in their research:
Maintenance of tissue culture of iPSCs; 10 μM Y-27632 for 24 hr; Montefiori et al (2018)
Reprogramming of breast cancer cells to induced progenitor-like cells (iPLs) ; 2 μM Y27632 ; Yuan et al (2018)
Differentiation - Y-27632 enables human embryonic stem cells to survive and differentiate into cortical and basal telencephalic progenitors; Watanabe et al (2007)
*Also available in simple stock solutions (ab144494) - add 1 ml of water to get an exact, ready-to-use concentration.
Properties and storage information
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ROCK1 and ROCK2 contribute significantly to the regulation of smooth muscle contraction actin cytoskeleton organization and cellular migration. They exist in their complex forms and primarily act by phosphorylating downstream target proteins which leads to changes in cell shape and movement. Their activity influences various cellular processes such as apoptotic regulation and tissue rigidity which are fundamental in development and homeostasis. Increased levels or activity of ROCKs link to pathological changes including vascular diseases and cancer progression.
Pathways
ROCK1 and ROCK2 are key components of the Rho/ROCK signaling pathway and the integrin-mediated signaling pathway. These pathways are vital for cellular activities like adhesion migration and proliferation. They often interact with other proteins such as LIM kinase and myosin phosphatase modulating actin-myosin contractility. The Rho/ROCK pathway in particular act as a hub for signal transduction connecting extracellular cues to intracellular responses. This pathway regulates many physiological responses by affecting various cellular substrates and signaling molecules.
Publications (153)
Recent publications for all applications. Explore the full list and refine your search
Theranostics 15:7127-7153 PubMed40585989
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:5266 PubMed40480969
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature methods 22:1213-1225 PubMed40419657
2025
Applications
Unspecified application
Species
Unspecified reactive species
Biotechnology and bioengineering 122:2206-2217 PubMed40400171
2025
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 2924:45-57 PubMed40307634
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 10: PubMed40059828
2025
Applications
Unspecified application
Species
Unspecified reactive species
Advanced science (Weinheim, Baden-Wurttemberg, Germany) 12:e2410110 PubMed39836549
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 8:94 PubMed39833279
2025
Applications
Unspecified application
Species
Unspecified reactive species
Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation 18:40-54 PubMed39433022
2024
Applications
Unspecified application
Species
Unspecified reactive species
Heliyon 10:e38214 PubMed39386786
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com